Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V L Yu

Showing results (161-170 of 269) with videos related to

Pageof 27
Sort By:
JAMA|August 29, 1977
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organismsV L Yu, F S Rhame, E L Pesanti, et al.
American Industrial Hygiene Association Journal|November 1, 1988
Legionnaires' disease in the work environment: implications for environmental healthP W Muraca, J E Stout, V L Yu, et al.
The Journal of Infectious Diseases|February 1, 1987
An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgeryJ T Johnson, V L Yu, E N Myers, et al.
The American Journal of the Medical Sciences|March 1, 1991
Empiric antibiotic selection by physicians: evaluation of reasoning strategiesV L Yu, G P Stoehr, R C Starling, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescriptionN Singh, P Rogers, C W Atwood, et al.
Transactions of the Association of American Physicians|January 1, 1980
Nosocomial outbreak of Legionnaire's disease at the Pittsburgh Veterans Administration Medical CenterA Brown, V L Yu, E M Elder, et al.
British Medical Journal (Clinical Research Ed.)|August 1, 1987
Discovery of occult legionella pneumonia in a long stay hospital: results of prospective serological surveyC Brennen, R M Vickers, V L Yu, et al.
The American Journal of Medicine|April 1, 1983
Simultaneous infection with Legionella pneumophila and Pittsburgh pneumonia agent. Clinical features and epidemiologic implicationsR R Muder, V L Yu, R M Vickers, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patientsV L Yu, J J Zuravleff, J E Peacock, et al.
Clinical Pharmacology and Therapeutics|July 1, 1981
Steady-state moxalactam kinetics: comparisons with other cephalosporinsP Garzone, J Lyon, V L Yu, et al.
Pageof 27

Showing results (161-170 of 269) with videos related to

Sort By:
Pageof 27
JAMA|August 29, 1977
Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organismsV L Yu, F S Rhame, E L Pesanti, et al.
American Industrial Hygiene Association Journal|November 1, 1988
Legionnaires' disease in the work environment: implications for environmental healthP W Muraca, J E Stout, V L Yu, et al.
The Journal of Infectious Diseases|February 1, 1987
An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgeryJ T Johnson, V L Yu, E N Myers, et al.
The American Journal of the Medical Sciences|March 1, 1991
Empiric antibiotic selection by physicians: evaluation of reasoning strategiesV L Yu, G P Stoehr, R C Starling, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescriptionN Singh, P Rogers, C W Atwood, et al.
Transactions of the Association of American Physicians|January 1, 1980
Nosocomial outbreak of Legionnaire's disease at the Pittsburgh Veterans Administration Medical CenterA Brown, V L Yu, E M Elder, et al.
British Medical Journal (Clinical Research Ed.)|August 1, 1987
Discovery of occult legionella pneumonia in a long stay hospital: results of prospective serological surveyC Brennen, R M Vickers, V L Yu, et al.
The American Journal of Medicine|April 1, 1983
Simultaneous infection with Legionella pneumophila and Pittsburgh pneumonia agent. Clinical features and epidemiologic implicationsR R Muder, V L Yu, R M Vickers, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1984
Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patientsV L Yu, J J Zuravleff, J E Peacock, et al.
Clinical Pharmacology and Therapeutics|July 1, 1981
Steady-state moxalactam kinetics: comparisons with other cephalosporinsP Garzone, J Lyon, V L Yu, et al.
Pageof 27